1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BEIGENE LTD - ADR
BeiGene Ltd - ADR XNAS: ONC
351.06 17.07 (5.11%)
359.6K
XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The latest board meeting for BeiGene Ltd (ADR) took place on 13 Jan 2026, for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details

BeiGene Ltd (ADR) - ONC - stock price prediction, stock price target, analyst ratings from 26 analysts

BeiGene Ltd (ADR) has a share price target of US$ 402, revenue growth forecast of 39.0%, and profit growth estimate of 151.0% for FY25, based on top 26 analyst calls.